Researchers shed light on how different SSRI antidepressants may work to help fight symptoms of depression in the brain.
Study reveals mindfulness-based stress reduction methods proved to be as effective as antidepressants for relieving symptoms for those with anxiety disorders.
Premenstrual dysphoric disorder (PMDD) is a severe mood disorder that affects one in twenty women. PMDD can have a debilitating impact on the lives of sufferers. Researchers investigate PMDD and evaluate treatment options for sufferers.
Researchers critique the latest findings on serotonin's role in depression and report people should maintain their current therapies to help control their symptoms of depression.
Researchers explain why the serotonin hypothesis for depression may not be as accurate as previously believed.
Many women experienced lingering depression throughout pregnancy and postpartum, despite using SSRI antidepressants, a new study reports.
People with untreated depression have lower levels of mitochondrial proteins. For those who responded to the SSRI antidepressants, the proteins returned to a normal level, but showed no increase in those who did not respond to medication.
A comparison of medical records reveals people who took SSRI antidepressants, specifically fluoxetine (Prozac), were less likely to die of COVID-19 than a matched control group. The findings add to a growing body of evidence that SSRIs may have beneficial effects against the worst symptoms of coronavirus.
The placebo effect combined with dopamine levels can determine whether symptoms of depression and social anxiety will improve in patients prescribed SSRI antidepressants. Researchers found the positive effect of the medications was four times higher in patients with high expectations the treatment would work compared to those with lower expectations.